Likewise, among four TEAD family members, expression of TEAD3 and TEAD4 was significantly higher in the SOH subgroup, further supporting isoform-specific activation of the YAP1/TAZ-TEAD pathway in GBM. The gene discussed is TEAD4; the disease is glioblastoma.